metricas
covid
Buscar en
Medicina de Familia. SEMERGEN
Toda la web
Inicio Medicina de Familia. SEMERGEN Dermatitis herpetiforme
Información de la revista
Vol. 30. Núm. 6.
Páginas 279-285 (junio 2004)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 30. Núm. 6.
Páginas 279-285 (junio 2004)
Acceso a texto completo
Dermatitis herpetiforme
Visitas
13481
J. Vergara Hernándeza,
Autor para correspondencia
juanvergarah@hotmail.com

Correspondencia: J. Vergara Hernández. Plaza de la Encarnación, 32. Portal 2,3°.B. 41003 Sevilla
, R. Díaz Peralb
a Médico de Familia. Centro de Salud Polígono Norte. Unidad Docente. Sevilla
b Médico Inspector. Unidad de Valoración Médica de Incapacidades. Sevilla
Este artículo ha recibido
Información del artículo

La dermatitis herpetiforme constituye una enfermedad crónica, hereditaria, de base inmune, que afecta preferentemente a la población del norte de Europa. Su frecuencia aproximada es de un caso por cada diez mil personas y predomina en varones con una relación de 1,5 a 1. Actualmente es considerada una forma de manifestación de la enfermedad celíaca, estando claramente demostrada la participación del gluten en el desarrollo de la misma. Clínicamente se caracteriza por lesiones cutáneas de tipo vesiculo-ampolloso, acompañadas de prurito intenso. Se ha puesto de manifiesto la elevación de los marcadores serológicos existentes en la enfermedad celíaca, aunque la única manera de establecer el diagnóstico definitivo es mediante la demostración de los depósitos granulares de inmunoglobulina A en la unión dermoepidérmica de piel sana o perilesional. En la totalidad de los casos está afectada la mucosa intestinal confirmándose mediante la realización de una biopsia duodenal. Aunque para el tratamiento sintomático se ha mostrado eficaz la dapsona, es fundamental el inicio de una dieta exenta de gluten para toda la vida.

Palabras clave:
dermatosis ampollosa
dermatitis herpetiforme
intolerancia al gluten

Dermatitis herpetiforme is a chronic, hereditary disease having an immune basis. It preferentially affects the Northern Europe population. Its approximate frequency is one case per every ten thousand persons and it predominates in males with a 1.5 to 1 ratio. At present, it is considered to be a manifestation form of celiac disease (CD), the participation of gluten being clearly demonstrated in its development. Clinically, it is characterized by vesicle-bullous type skin lesions, accompanied by intense itching. Increase of the serological markers existing in CD has been manifested, although the only way of establishing the definite diagnosis is by demonstration of granular IgA deposits in the dermoepidermic junction of healthy or perilesional skin. In all the cases, the intestinal mucosa is involved, which is verified by a duodenal biopsy. Although dapsone has been shown to be effective for symptomatic treatment, initiation of a gluten free diet for all one's life is essential.

Key words:
bullous dermatosis
dermatitis herpetiforme
gluten intolerance
El Texto completo está disponible en PDF
Biblografía
[1.]
L. Duhring.
Dermatitis herpetiformis.
JAMA, 3 (1884), pp. 225
[2.]
T. Reunala.
Dermatitis herpetiformis: coeliac disease of the skin.
Ann Med, 30 (1998), pp. 416-418
[3.]
D.J. Gawkrodger, J.N. Blackwell, H.M. Gilmore.
Dermatitis herpetiformis: diagnosis, diet and dermography.
Gut, 25 (1984), pp. 151-157
[4.]
T. Reunala, J. Lokki.
Dermatitis herpetiformis in Finland.
Acta Dermato-Venereol, 58 (1978), pp. 505-510
[5.]
H. Mobracken, W. Kastrup, L.A. Nilsson.
Incidence and prevalence of dermatitis herpetiformis in western Sweden.
Acta Dermato-Venereol, 64 (1984), pp. 400-404
[6.]
H. Moi.
Incidence and prevalence of dermatitis herpetiformis in a country in central Sweden, with comments on the course of the disease and IgA deposits as diagnostic criterion.
Acta Dermato-Venereol, 64 (1984), pp. 144-150
[7.]
O.B. Christensen, M. Hindsen, A. Svensson.
Natural history of dermatitis herpetiformis in southern Sweden.
Dermatológica, 173 (1986), pp. 271-277
[8.]
J.B. Smith, J.E. Tulloch, L.J. Meyer, J.J. Zone.
The incidence and prevalence of dermatitis herpetiformis in Utah.
Arch Dermatol, 128 (1992), pp. 1608-1610
[9.]
L. Fry.
Dermatitis herpetiformis.
Baillière's Clinical Gastroenterology, 2 (1995), pp. 371-393
[10.]
L. Fry, P. Keir, R.M.H. McMinn.
Small intestinal structure and function, and haematological changes in dermatitis herpetiformis.
Lancet, ii (1967), pp. 729-734
[11.]
L. Fry, R.M.H. McMinn, J.D. Cowan, A.V. Hoffbrand.
Effect of glutenfree diet on dermatological, intestinal and haematological manifestations of dermatitis herpetiformis.
Lancet, i (1968), pp. 557-561
[12.]
L. Fry, R.M.H. McMinn, J.D. Cowan, A.V. Hoffbrand.
Gluten-free diet and reintroduction of gluten in dermatitis herpetiformis.
Arch Dermatol, 100 (1969), pp. 129-135
[13.]
L. Fry, P.P. Seath, D.J. Riches, A.V. Hoffbrand.
Clearence of skin lesions in dermatitis herpetiformis after gluten withdrawal.
Lancet, i (1973), pp. 288-291
[14.]
L. Fry, J.N. Leonard, A.F. Swain.
Long term follow up of dermatitis herpetiformis with and without dietary gluten withdrawal.
Br J Dermatol, 107 (1982), pp. 631-640
[15.]
T.A. Greenberg, S.E. Hodge, J.I. Rother.
Evidence for recessive and against dominant inheritance at the HLA linked locus in coeliac disease.
Am J Human Gen, 34 (1982), pp. 263-277
[16.]
T. Reunala, S. Koskimies.
Familial dermatitis herpetiformis.
Clin Dermatol, 9 (1991), pp. 335-340
[17.]
T. Reunala, O.P. Salo, P. Tilikainen.
Family studies in dermatitis herpetiformis.
Ann Clin Res, 8 (1976), pp. 254-261
[18.]
A. Balas, J.L. Vicario, A. Zambrano, D. Acuna, D. Garcia-Novo.
Absolute linkage of celiac disease and dermatitis herpetiformis to HLADQ.
Tissue Antigens, 50 (1997), pp. 52-56
[19.]
L. Fry, P.P. Seah, P.G. Harper.
The small intestine in dermatitis herpetiformis.
J Clin Pathol, 27 (1974), pp. 817-824
[20.]
R.P. Hall, K.D. McKenzie.
Comparison of the intestinal and serum antibody response in patients with dermatitis herpetiformis.
Clin Inmunol Inmunopathol, 1992 (1992), pp. 33-41
[21.]
M. Graeber, B.S. Baker, J.J. Garioch.
The role of cytokines in the generation of skin lesions in dermatitis herpetiformis.
Br J Dermatol, 129 (1993), pp. 530-532
[22.]
E. Savilahti, T. Ormala, A. Arato, G. Hacsek, K. Holm, T. Klemola, et al.
Density of gamma/delta+ T cells in the jejunal epithelium of patients with coeliac disease and dermatitis herpetiformis is increased with age.
Clin Exp Immunol, 109 (1997), pp. 464-467
[23.]
W. Dieterich.
Identification of tissue transglutaminase as the autoantigen of celiac disease.
Nature Med, 3 (1997), pp. 797-801
[24.]
J.J. Garioch, H.M. Lewis, S.A. Sargent, J.N. Leonard, L. Fry.
25 years' experience of a gluten-free diet in the treatment of dermatitis herpetiformis.
Br J Dermatol, 131 (1994), pp. 541-545
[25.]
B.G. Cuartero, M.J. Santamaria, M.D. Acuna Quiros, J. Martínez Gómez, M. Romero Portilla, C. Pedron Giner, et al.
Dermatitis herpetiformis vs. celiac disease.
An Exp Pediatric, 37 (1992), pp. 307-310
[26.]
N. Demoulins-Giacco, V. Gagey, D. Teillac-Hamel, S. Fraitag, S. Caillat-Zucman, J. Schmitz, et al.
Dermatitis herpetiformis occuring in patients with celiac disease in childhood.
Arch Pediatric, 3 (1996), pp. 541-548
[27.]
A.P. Weetman, J.M. Burrin, D. Mackay.
The prevalence of thyriod auto-antibodies in dermatitis herpetiformis.
Br J Dermatol, 118 (1988), pp. 377-386
[28.]
J.P. McFadden, J.N. Leonard, A.V. Powles, L. Fry.
Autoimmunity in dermatitis herpetiformis: effect of a gluten free diet.
J Dermatol Treat, 2 (1991), pp. 87-90
[29.]
T. Reunala, P. Collin.
Disease associated with dermatitis herpetiformis.
Br J Dermatol, 136 (1997), pp. 315-318
[30.]
B. Sigurgiersson, M. Agnarsson, B. Lindelof.
Risk of limphoma in patients with dermatitis herpetiformis.
Br Med J, 308 (1994), pp. 13-15
[31.]
F. Wojnarowska, L. Fry.
Hepatic injury in dermatitis herpetiformis.
Acta Dermato-Venereol, 61 (1981), pp. 165-168
[32.]
D.J. Unsworth, J.N. Leonard, R.M.H. McMinn.
Antigliadin antibodies and small intestinal mucosal damage in dermatitis herpetiformis.
Br J Dermatol, 105 (1981), pp. 6538
[33.]
P.P. Seah, L. Fry, E.J. Holborow.
Antireticulin antibody: incidence and diagnostic significance.
Gut, 14 (1973), pp. 311-315
[34.]
J. Sulej, J.N. Leonard.
Anti-endomysial antibidies in dermatitis herpetiformis and coeliac disease.
Immunologopathology of skin, pp. 477-482
[35.]
C. Rose, W. Dieterich, E.B. Brocker, D. Schuppan, D. Zillikens.
Circulating autoantibodies to tissue transglutaminase differentiate patients with dermatitis herpetiformis from those with linear disease.
J Acad Dermatol, 41 (1999), pp. 957-961
[36.]
P. Humbert Yagüe, E. García Planella, V. Moreno de Vega.
Manifestaciones clínicas y tratamiento de la enfermedad celíaca del adulto.
JANO, 1310 (1999), pp. 40-45
[37.]
B. Rye, J.M. Webb.
Autoimmune bullous disease.
Am Fam Physic, 55 (1997), pp. 2709-2718
[38.]
J.M. Mascaró.
Las dermatosis. 1.a ed.
[39.]
A. García.
Dermatosis por parásitos metazoos.
Dermatología Clínica. 3.a ed, pp. 42-47
[40.]
J. Vergara Hernández, M.R. Díaz Peral.
Celiaquía y Atención Primaria.
Semergen, 1 (2001), pp. 14-23
[41.]
A. Ventura, G. Magazzu, L. Greco.
Duration of exposure to gluten and risk for autoinmune disorders in patients with celiac disease.
Gastroenterology, 117 (1999), pp. 297-303
[42.]
G.K.T. Holmes, P. Prior, M.R. Lane.
Malignancy in coeliac disease-effect of a gluten-free diet.
Gut, 30 (1989), pp. 33-38
[43.]
S.K. Bose, J.P. Lacour, Bodokh, J.P. Ortonne.
Malignant lymphoma and dermatitis herpetiformis.
Dermatology, 188 (1994), pp. 177-181
[44.]
J. Vergara Hernández.
Carta al Director.
Medicina General, 32 (2001), pp. 219
Copyright © 2004. Elsevier España, S.L. y Sociedad Española de Medicina Rural y Generalista (SEMERGEN)
Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos